EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 86 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,885,663 | -26.1% | 2,946,887 | 0.0% | 0.98% | -23.0% |
| Q2 2023 | $22,838,374 | +116090.3% | 2,946,887 | 0.0% | 1.28% | -1.2% |
| Q1 2023 | $19,656 | -25.4% | 2,946,887 | 0.0% | 1.29% | -26.6% |
| Q4 2022 | $26,345 | -99.9% | 2,946,887 | -3.4% | 1.76% | -16.0% |
| Q3 2022 | $30,032,000 | -2.0% | 3,051,989 | -20.7% | 2.10% | -9.4% |
| Q2 2022 | $30,646,000 | -32.5% | 3,850,000 | -17.8% | 2.32% | -33.6% |
| Q1 2022 | $45,424,000 | -16.6% | 4,682,874 | +31.3% | 3.49% | +7.6% |
| Q4 2021 | $54,487,000 | -2.6% | 3,565,901 | +5.8% | 3.24% | +42.5% |
| Q3 2021 | $55,957,000 | -15.9% | 3,370,914 | +7.3% | 2.27% | +0.6% |
| Q2 2021 | $66,530,000 | -10.5% | 3,140,914 | +34.2% | 2.26% | +36.6% |
| Q1 2021 | $74,307,000 | – | 2,340,914 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |